LUTETIUM 177-LABELED CETUXIMAB EVALUATION FOR RADIO IMMUNOTHERAPEUTIC APPLICATIONS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

YAVARI K.; GHANNADI M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Ardabil University of Medical Sciences Year:2012 | Volume:12 | Issue:2 (44) Page(s): 204-212

Download Full-Text

Persian Verion

View:

925

Download:

Cites:

Information Journal Paper

Title

LUTETIUM 177-LABELED CETUXIMAB EVALUATION FOR RADIO IMMUNOTHERAPEUTIC APPLICATIONS

Author(s)

YAVARI K. | GHANNADI M. | Issue Writer Certificate

Keywords

CETUXIMABQ2

RADIO IMMUNOTHERAPYQ2

177LUQ2

DOTA-NHSQ2

Abstract

Background & Objectives: The monoclonal antibody CETUXIMAB binds to EGFR and thus provides an opportunity to create both imaging and therapeutic modalities that target this receptor. The potential of CETUXIMAB as a radio immunoconjugate was investigated and quality control tests (in vitro and in vivo) were performed as a first step in the production of a new radiopharmaceutical.Methods: CETUXIMAB solution was dialyzed and concentrated using an Amicon Ultra-15 filter.Purified antibody was labeled with lutetium-177 using the acyclic bifunctional chelator, DOTA-NHS, and radio immunoconjugates were purified by PD10 columns. Radiochemical purity and stability in buffer and human blood serum were determined using thin layer chromatography. Integrity of the radiolabeled complex was checked by SDS-PAGE.Preliminary biodistribution studies in normal mice model performed to determine radio immunoconjugates distribution up to 72h.Results: The radiochemical purity of the complex was 98±1%. The stabilities in phosphate buffer and in human blood serum at 96 hours post-preparation were 96±2 % and 78±4%, respectively. All of the samples, controls and radiolabeled antibodies, showed a similar pattern of migration in the gel electrophoresis. Biodistribution of Lu177-CETUXIMAB was evaluated in normal mice and the highest ID/g% was observed in the blood (13.2±1.3% at 24 hours) and the liver (9.1±1.3% at 24 hours).Conclusion: Our results show that DOTA-cituximab can be labeled with 177Lu. Lu177-CETUXIMAB has sufficient stability and retains its integrity. The new complex could be considered for further evaluation in animals and possibly in humans as a new radiopharmaceutical for use in RADIO IMMUNOTHERAPY of cancers.

Cites

No record.

References

No record.

Cite

APA: Copy

YAVARI, K., & GHANNADI, M.. (2012). LUTETIUM 177-LABELED CETUXIMAB EVALUATION FOR RADIO IMMUNOTHERAPEUTIC APPLICATIONS. JOURNAL OF ARDABIL UNIVERSITY OF MEDICAL SCIENCES (JAUMS), 12(2 (44)), 204-212. SID. https://sid.ir/paper/60060/en

Vancouver: Copy

YAVARI K., GHANNADI M.. LUTETIUM 177-LABELED CETUXIMAB EVALUATION FOR RADIO IMMUNOTHERAPEUTIC APPLICATIONS. JOURNAL OF ARDABIL UNIVERSITY OF MEDICAL SCIENCES (JAUMS)[Internet]. 2012;12(2 (44)):204-212. Available from: https://sid.ir/paper/60060/en

IEEE: Copy

K. YAVARI, and M. GHANNADI, “LUTETIUM 177-LABELED CETUXIMAB EVALUATION FOR RADIO IMMUNOTHERAPEUTIC APPLICATIONS,” JOURNAL OF ARDABIL UNIVERSITY OF MEDICAL SCIENCES (JAUMS), vol. 12, no. 2 (44), pp. 204–212, 2012, [Online]. Available: https://sid.ir/paper/60060/en

Related Journal Papers